P3 Health Partners Inc. Class A Common Stock (PIII)

FairStock Score: 17/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for understandable businesses with durable earnings and a margin of safety. P3 Health Partners is a physician-led population health manager with clinics and wellness centers, founded in 2020. Scale is real: fiscal 2025 revenue was $1.5B, and the quarters ended 2026-03-31 and 2026-06-30 each produced $386.4M of revenue. The most recent filed quarter, fiscal Q2 2026, showed $7.4M of net income, and fiscal Q1 2026 showed $1.2M, which is encouraging after years of losses. But those small profits sit against fiscal 2025 net loss of $147.9M, fiscal 2024 net loss of $135.8M, and fiscal 2023 net loss of $57.8M. FairStock's Lynch category is none because it has lost money in each of the last four years. Cash generation is the bigger warning: trailing free cash flow was -$130.5M, a -963.3% yield on the $13.5M market cap at the 2026-10-13 close. FairStock's ROE is -192.58%, ROCE is -13.40%, D/E is 0.95, Altman Z-score is -0.94, and Piotroski is 5/9, a profile that demands caution. The stock trades at $4.03, with a FairStock P/E of -0.12. The market values the entire equity at only $13.5M against $1.5B of fiscal 2025 revenue, which looks statistically cheap; however, a low price relative to sales is not a margin of safety if losses persist. The two recent profitable quarters are early evidence the model might work, but I would need several more quarters of positive net income and positive free cash flow, plus a stronger balance sheet, before calling this a sound value investment.

In plain English: P3 Health Partners runs clinics and wellness centers and helps manage patient health. It has lost money in recent years, though the two most recent reported quarters showed small profits. At $4.03, the stock looks very cheap next to its yearly sales, but the company burns a lot of cash, so it is not a safe-looking bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer